Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Opposing T cell responses in experimental autoimmune encephalomyelitis.

Saligrama N, Zhao F, Sikora MJ, Serratelli WS, Fernandes RA, Louis DM, Yao W, Ji X, Idoyaga J, Mahajan VB, Steinmetz LM, Chien YH, Hauser SL, Oksenberg JR, Garcia KC, Davis MM.

Nature. 2019 Aug;572(7770):481-487. doi: 10.1038/s41586-019-1467-x. Epub 2019 Aug 7.

PMID:
31391585
2.

Nursing Markedly Protects Postpartum Mice From Stroke: Associated Central and Peripheral Neuroimmune Changes and a Role for Oxytocin.

Stary CM, Xu L, Voloboueva LA, Alcántara-Hernández M, Arvola OJ, Idoyaga J, Giffard RG.

Front Neurosci. 2019 Jul 8;13:609. doi: 10.3389/fnins.2019.00609. eCollection 2019.

3.

The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.

Antonio-Herrera L, Badillo-Godinez O, Medina-Contreras O, Tepale-Segura A, García-Lozano A, Gutierrez-Xicotencatl L, Soldevila G, Esquivel-Guadarrama FR, Idoyaga J, Bonifaz LC.

Front Immunol. 2018 Sep 27;9:2212. doi: 10.3389/fimmu.2018.02212. eCollection 2018.

4.

Vaccination-induced skin-resident memory CD8+ T cells mediate strong protection against cutaneous melanoma.

Gálvez-Cancino F, López E, Menares E, Díaz X, Flores C, Cáceres P, Hidalgo S, Chovar O, Alcántara-Hernández M, Borgna V, Varas-Godoy M, Salazar-Onfray F, Idoyaga J, Lladser A.

Oncoimmunology. 2018 Mar 19;7(7):e1442163. doi: 10.1080/2162402X.2018.1442163. eCollection 2018.

5.

High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization.

Alcántara-Hernández M, Leylek R, Wagar LE, Engleman EG, Keler T, Marinkovich MP, Davis MM, Nolan GP, Idoyaga J.

Immunity. 2017 Dec 19;47(6):1037-1050.e6. doi: 10.1016/j.immuni.2017.11.001. Epub 2017 Dec 5.

6.

Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination.

Lüdtke A, Ruibal P, Wozniak DM, Pallasch E, Wurr S, Bockholt S, Gómez-Medina S, Qiu X, Kobinger GP, Rodríguez E, Günther S, Krasemann S, Idoyaga J, Oestereich L, Muñoz-Fontela C.

Sci Rep. 2017 Mar 3;7:43776. doi: 10.1038/srep43776.

7.

Pseudogenization of the Secreted Effector Gene sseI Confers Rapid Systemic Dissemination of S. Typhimurium ST313 within Migratory Dendritic Cells.

Carden SE, Walker GT, Honeycutt J, Lugo K, Pham T, Jacobson A, Bouley D, Idoyaga J, Tsolis RM, Monack D.

Cell Host Microbe. 2017 Feb 8;21(2):182-194. doi: 10.1016/j.chom.2017.01.009.

8.

Monocyte-derived dendritic cells enhance protection against secondary influenza challenge by controlling the switch in CD8+ T-cell immunodominance.

Cruz JL, Pérez-Girón JV, Lüdtke A, Gómez-Medina S, Ruibal P, Idoyaga J, Muñoz-Fontela C.

Eur J Immunol. 2017 Feb;47(2):345-352. doi: 10.1002/eji.201646523. Epub 2016 Dec 9.

9.

Ebola Virus Disease Is Characterized by Poor Activation and Reduced Levels of Circulating CD16+ Monocytes.

Lüdtke A, Ruibal P, Becker-Ziaja B, Rottstegge M, Wozniak DM, Cabeza-Cabrerizo M, Thorenz A, Weller R, Kerber R, Idoyaga J, Magassouba N, Gabriel M, Günther S, Oestereich L, Muñoz-Fontela C.

J Infect Dis. 2016 Oct 15;214(suppl 3):S275-S280. Epub 2016 Aug 11.

PMID:
27521367
10.

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N, Chakarov S, Rivera C, Hogstad B, Bosenberg M, Hashimoto D, Gnjatic S, Bhardwaj N, Palucka AK, Brown BD, Brody J, Ginhoux F, Merad M.

Immunity. 2016 Apr 19;44(4):924-38. doi: 10.1016/j.immuni.2016.03.012.

11.

Reply to: "Subverting misconceptions about radiation therapy".

Price JG, Idoyaga J, Merad M.

Nat Immunol. 2016 Apr;17(4):345-6. doi: 10.1038/ni.3376. No abstract available.

PMID:
27002832
12.

CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation.

Price JG, Idoyaga J, Salmon H, Hogstad B, Bigarella CL, Ghaffari S, Leboeuf M, Merad M.

Nat Immunol. 2015 Oct;16(10):1060-8. doi: 10.1038/ni.3270. Epub 2015 Sep 7.

13.

ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.

Silva-Sánchez A, Meza-Pérez S, Flores-Langarica A, Donis-Maturano L, Estrada-García I, Calderón-Amador J, Hernández-Pando R, Idoyaga J, Steinman RM, Flores-Romo L.

PLoS One. 2015 Apr 27;10(4):e0124828. doi: 10.1371/journal.pone.0124828. eCollection 2015.

14.

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrão M, Lira SA, Heym KM, Clausen BE, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE.

J Exp Med. 2015 Feb 9;212(2):281. doi: 10.1084/jem.2013097701202015c. Epub 2015 Feb 2. No abstract available.

15.

Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses.

Godefroy E, Gallois A, Idoyaga J, Merad M, Tung N, Monu N, Saenger Y, Fu Y, Ravindran R, Pulendran B, Jotereau F, Trombetta S, Bhardwaj N.

Cell Rep. 2014 Dec 11;9(5):1856-1870. doi: 10.1016/j.celrep.2014.10.067. Epub 2014 Nov 26.

16.

Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.

Flacher V, Tripp CH, Mairhofer DG, Steinman RM, Stoitzner P, Idoyaga J, Romani N.

EMBO Mol Med. 2014 Sep;6(9):1191-204. doi: 10.15252/emmm.201303283. Erratum in: EMBO Mol Med. 2014 Dec;6(12):1638.

17.

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrão M, Lira SA, Heym KM, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE.

J Exp Med. 2014 Apr 7;211(4):669-83. doi: 10.1084/jem.20130977. Epub 2014 Mar 17. Erratum in: J Exp Med. 2015 Feb 9;212(2):281.

18.

Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.

Matos I, Mizenina O, Lubkin A, Steinman RM, Idoyaga J.

PLoS One. 2013 Jun 26;8(6):e67453. doi: 10.1371/journal.pone.0067453. Print 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/5149bf8e-3843-4865-a726-0ca2820ee8f8.

19.

Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells.

Barbuto S, Idoyaga J, Vila-Perelló M, Longhi MP, Breton G, Steinman RM, Muir TW.

Nat Chem Biol. 2013 Apr;9(4):250-6. doi: 10.1038/nchembio.1186. Epub 2013 Feb 17.

20.

Specialized role of migratory dendritic cells in peripheral tolerance induction.

Idoyaga J, Fiorese C, Zbytnuik L, Lubkin A, Miller J, Malissen B, Mucida D, Merad M, Steinman RM.

J Clin Invest. 2013 Feb;123(2):844-54. doi: 10.1172/JCI65260. Epub 2013 Jan 9.

21.

Streamlined expressed protein ligation using split inteins.

Vila-Perelló M, Liu Z, Shah NH, Willis JA, Idoyaga J, Muir TW.

J Am Chem Soc. 2013 Jan 9;135(1):286-92. doi: 10.1021/ja309126m. Epub 2012 Dec 24.

22.

Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state.

Meredith MM, Liu K, Kamphorst AO, Idoyaga J, Yamane A, Guermonprez P, Rihn S, Yao KH, Silva IT, Oliveira TY, Skokos D, Casellas R, Nussenzweig MC.

J Exp Med. 2012 Aug 27;209(9):1583-93. doi: 10.1084/jem.20121003. Epub 2012 Jul 30.

23.

Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage.

Meredith MM, Liu K, Darrasse-Jeze G, Kamphorst AO, Schreiber HA, Guermonprez P, Idoyaga J, Cheong C, Yao KH, Niec RE, Nussenzweig MC.

J Exp Med. 2012 Jun 4;209(6):1153-65. doi: 10.1084/jem.20112675. Epub 2012 May 21.

24.

Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice.

Billiard F, Lobry C, Darrasse-Jèze G, Waite J, Liu X, Mouquet H, DaNave A, Tait M, Idoyaga J, Leboeuf M, Kyratsous CA, Burton J, Kalter J, Klinakis A, Zhang W, Thurston G, Merad M, Steinman RM, Murphy AJ, Yancopoulos GD, Aifantis I, Skokos D.

J Exp Med. 2012 May 7;209(5):1011-28. doi: 10.1084/jem.20111615. Epub 2012 Apr 30.

25.

Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.

Flacher V, Tripp CH, Haid B, Kissenpfennig A, Malissen B, Stoitzner P, Idoyaga J, Romani N.

J Immunol. 2012 Mar 1;188(5):2146-55. doi: 10.4049/jimmunol.1004120. Epub 2012 Jan 30.

26.

Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein.

Hemmi H, Zaidi N, Wang B, Matos I, Fiorese C, Lubkin A, Zbytnuik L, Suda K, Zhang K, Noda M, Kaisho T, Steinman RM, Idoyaga J.

J Immunol. 2012 Feb 1;188(3):1147-55. doi: 10.4049/jimmunol.1102541. Epub 2011 Dec 30.

27.

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity.

Trumpfheller C, Longhi MP, Caskey M, Idoyaga J, Bozzacco L, Keler T, Schlesinger SJ, Steinman RM.

J Intern Med. 2012 Feb;271(2):183-92. doi: 10.1111/j.1365-2796.2011.02496.x. Epub 2012 Jan 4. Review.

28.

SnapShot: Dendritic Cells.

Idoyaga J, Steinman RM.

Cell. 2011 Aug 19;146(4):660-660.e2. doi: 10.1016/j.cell.2011.08.010. No abstract available.

29.

Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.

Idoyaga J, Lubkin A, Fiorese C, Lahoud MH, Caminschi I, Huang Y, Rodriguez A, Clausen BE, Park CG, Trumpfheller C, Steinman RM.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2384-9. doi: 10.1073/pnas.1019547108. Epub 2011 Jan 24.

30.

Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas.

Cheong C, Matos I, Choi JH, Dandamudi DB, Shrestha E, Longhi MP, Jeffrey KL, Anthony RM, Kluger C, Nchinda G, Koh H, Rodriguez A, Idoyaga J, Pack M, Velinzon K, Park CG, Steinman RM.

Cell. 2010 Oct 29;143(3):416-29. doi: 10.1016/j.cell.2010.09.039.

31.

Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy.

Romani N, Thurnher M, Idoyaga J, Steinman RM, Flacher V.

Immunol Cell Biol. 2010 May-Jun;88(4):424-30. doi: 10.1038/icb.2010.39. Epub 2010 Apr 6. Review.

32.

Features of the dendritic cell lineage.

Steinman RM, Idoyaga J.

Immunol Rev. 2010 Mar;234(1):5-17. doi: 10.1111/j.0105-2896.2009.00888.x. No abstract available.

PMID:
20193008
33.

Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells.

Gottfried-Blackmore A, Kaunzner UW, Idoyaga J, Felger JC, McEwen BS, Bulloch K.

Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20918-23. doi: 10.1073/pnas.0911509106. Epub 2009 Nov 11.

34.

Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis.

Flacher V, Tripp CH, Stoitzner P, Haid B, Ebner S, Del Frari B, Koch F, Park CG, Steinman RM, Idoyaga J, Romani N.

J Invest Dermatol. 2010 Mar;130(3):755-62. doi: 10.1038/jid.2009.343. Epub 2009 Nov 5.

35.

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.

Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, Salazar AM, Colonna M, Steinman RM.

J Exp Med. 2009 Jul 6;206(7):1589-602. doi: 10.1084/jem.20090247. Epub 2009 Jun 29.

36.

Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen.

Idoyaga J, Suda N, Suda K, Park CG, Steinman RM.

Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1524-9. doi: 10.1073/pnas.0812247106. Epub 2009 Jan 23.

38.

Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo.

Idoyaga J, Cheong C, Suda K, Suda N, Kim JY, Lee H, Park CG, Steinman RM.

J Immunol. 2008 Mar 15;180(6):3647-50.

39.

Generation and application of new rat monoclonal antibodies against synthetic FLAG and OLLAS tags for improved immunodetection.

Park SH, Cheong C, Idoyaga J, Kim JY, Choi JH, Do Y, Lee H, Jo JH, Oh YS, Im W, Steinman RM, Park CG.

J Immunol Methods. 2008 Feb 29;331(1-2):27-38. Epub 2007 Nov 26.

40.

Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207.

Cheong C, Idoyaga J, Do Y, Pack M, Park SH, Lee H, Kang YS, Choi JH, Kim JY, Bonito A, Inaba K, Yamazaki S, Steinman RM, Park CG.

J Immunol Methods. 2007 Jul 31;324(1-2):48-62. Epub 2007 May 24.

41.

Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands.

Idoyaga J, Moreno J, Bonifaz L.

Cancer Immunol Immunother. 2007 Aug;56(8):1237-50. Epub 2007 Jan 20.

PMID:
17237931
42.

Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells.

Liu K, Idoyaga J, Charalambous A, Fujii S, Bonito A, Mordoh J, Wainstok R, Bai XF, Liu Y, Steinman RM.

J Exp Med. 2005 Dec 5;202(11):1507-16.

43.

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.

Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R.

J Immunol. 2003 Dec 1;171(11):5940-7.

Supplemental Content

Loading ...
Support Center